__________________________________________________________________________________________
Re: Global ID / Local ID: TH201412000166/ TH141103877 FU (1)
Thank you for reporting to us an adverse event related to Lilly product(s).
We would like to collect more information to better understanding the reported event.
Please respond to following question regarding the adverse event – hard lump in left breast got bigger/ not cancer, involving a female patient, aged 66, who was subscribed Forteo, reported the event to Lilly on 25-Nov-2014.
Please provide the informatoin for following:
1. Please provide the indication of teriparatide treatment.
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
2. Please provide if any concomitant medications were taken?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
3. Please provide laboratory findings and final diagnosis of the event breast lump.
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
4. Please provide the relatedness opinion for the event.
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
5. Please provide whether the patient recovered from the event.
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
6. Risk factors (postmenopausal hormone use, family history of breast cancer or benign breast conditions).
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: